Cellenkos 2
Pharma & Biotech company headquartered in Houston, TX. Cross-border supply chain, facility locations, and freight intelligence below.
Cellenkos, Inc # About Cellenkos We are a patient-centric, clinical stage, allogeneic T regulatory cell therapy biotechnology team focused on treating Rare Inflammatory Diseases. Cellenkos was founded in 2016 with the licensing of a proprietary umbilical cord blood T-Regulatory (Tregs) cell therapy platform from MD Anderson Cancer Center and funded by Golden Meditech Holdings Ltd, a Hong Kong-based integrated healthcare enterprise. Because they are derived from umbilical cord blood, Cellenkos’ T
- Industry
- Pharma & Biotech
- Headquarters
- Houston, TX
- Employees
- 50
- US facilities
- Houston, TX
Start a free trial to see Cellenkos 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.